STOCK TITAN

Associated Banc-Corp (ASB) director awarded 3,582-share RSU equity grant

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Kotouc Wende L reported acquisition or exercise transactions in this Form 4 filing.

ASSOCIATED BANC-CORP director Wende L. Kotouc received an equity grant as part of board compensation. The filing shows an award of 3,582 shares of common stock at a reference value of $26.17 per share, structured as a Restricted Stock Unit grant.

The RSU award represents the 2026 equity portion of compensation for serving as a director and will become fully vested on February 1, 2027. It is payable solely in shares of common stock upon vesting and is not eligible for deferral. After this grant, Kotouc holds 1,776,714 shares directly, plus additional indirect holdings attributed to a child and spouse.

Positive

  • None.

Negative

  • None.
Insider Kotouc Wende L
Role Director
Type Security Shares Price Value
Grant/Award Common Stock $0.01 Par Value 3,582 $26.17 $94K
holding Common Stock $0.01 Par Value -- -- --
holding Common Stock $0.01 Par Value -- -- --
Holdings After Transaction: Common Stock $0.01 Par Value — 1,776,714 shares (Direct); Common Stock $0.01 Par Value — 616 shares (Indirect, Child)
Footnotes (1)
  1. [object Object]
RSU shares granted 3,582 shares Restricted Stock Unit award representing 2026 equity compensation
Grant reference price $26.17 per share Reported value for the 3,582-share RSU grant
Direct holdings after grant 1,776,714 shares Common stock directly held by Wende L. Kotouc after the transaction
Indirect child holdings 616 shares Common stock indirectly held through a child relationship
Indirect spouse holdings 8,321,731 shares Common stock indirectly attributed to spouse
RSU vesting date February 1, 2027 Date when the RSU award becomes fully vested
Restricted Stock Unit financial
"Pro-rated portion of annual Restricted Stock Unit award, which will become fully vested"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
equity portion of the Reporting Person's compensation financial
"This grant represents the 2026 equity portion of the Reporting Person's compensation"
payable solely in shares of common stock financial
"Payable solely in shares of common stock upon vesting and not eligible for deferral"
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Kotouc Wende L

(Last)(First)(Middle)
C/O ASSOCIATED BANC-CORP
433 MAIN STREET

(Street)
GREEN BAY WISCONSIN 54301

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
ASSOCIATED BANC-CORP [ ASB ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock $0.01 Par Value04/01/2026A(1)3,582A$26.171,776,714D
Common Stock $0.01 Par Value616IChild
Common Stock $0.01 Par Value8,321,731ISpouse
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Pro-rated portion of annual Restricted Stock Unit award, which will become fully vested on February 1, 2027. Payable solely in shares of common stock upon vesting and not eligible for deferral. This grant represents the 2026 equity portion of the Reporting Person's compensation while serving as a Director for the Issuer.
/s/ Lynn M. Floeter, by POA from Wende L. Kotouc04/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did ASB director Wende L. Kotouc report in this Form 4?

Wende L. Kotouc reported receiving a grant of 3,582 shares of Associated Banc-Corp common stock. This award is part of her 2026 equity compensation for serving as a director and is structured as a Restricted Stock Unit grant that vests in the future.

Is the ASB Form 4 filing a stock purchase or a compensation grant?

The Form 4 reflects a compensation grant, not an open-market stock purchase. Kotouc received 3,582 Restricted Stock Units as the 2026 equity portion of her director compensation, with settlement in shares of Associated Banc-Corp common stock upon vesting rather than a cash transaction.

When do Wende L. Kotouc’s ASB Restricted Stock Units vest?

The Restricted Stock Unit award will become fully vested on February 1, 2027. Once vested, it is payable solely in shares of Associated Banc-Corp common stock, meaning Kotouc will receive company shares rather than cash or deferred units at that vesting date.

How many ASB shares does Wende L. Kotouc hold after this grant?

After the grant, Kotouc directly holds 1,776,714 shares of Associated Banc-Corp common stock. The filing also reports indirect holdings of 616 shares attributed to a child and 8,321,731 shares attributed to a spouse, providing a fuller picture of related holdings.

What is the reference price for the ASB equity grant to Wende L. Kotouc?

The RSU grant is reported at a reference value of $26.17 per share for 3,582 shares. This figure typically reflects the grant-date fair value used for compensation reporting and does not indicate an open-market purchase or sale price in this Form 4 filing.